7181Panorama de las tecnologías para el tratamiento de desechos infecciosos y punzocortantes en los centros de saludPublications · 30 juillet 2020
7182Buruli ulcer laboratory network and new external quality assessment programme for PCR-based diagnosis in the WHO African Region: terms of referencePublications · 30 juillet 2020
7183First meeting of the network on Buruli ulcer PCR laboratories in the WHO African Region: centre pasteur du Cameroon, Yaoundé, 21-24 October 2019Publications · 30 juillet 2020
7184WHO antenatal care recommendations for a positive pregnancy experience: nutritional interventions update: vitamin D supplements during pregnancyPublications · 30 juillet 2020
7185Promoting access to medical technologies and innovation: intersections between public health, intellectual property and tradePublications · 29 juillet 2020
7186Training modules on Hepatitis B and C screening, diagnosis and treatmentPublications · 29 juillet 2020
7187International coordination group on vaccine provision for yellow fever: report of the annual meeting, Geneva, 12 September 2019Publications · 28 juillet 2020
7188Implementation of novel oral polio vaccine type 2 (nOPV2) for circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak response: technical guidance for countriesPublications · 28 juillet 2020
7189Protocole type pour la surveillance des délétions des gènes pfhrp2/pfhrp3Publications · 28 juillet 2020
7190Institutionnalisation de la prise en charge intégrée des maladies de l’enfance dans la communauté (PCIME) pour mettre fin aux décès évitables d’enfants : consultation technique et plan d’action par pays, 22-26 juillet 2019, Addis-AbebaPublications · 28 juillet 2020
7191Institutionalizing integrated community case management (iCCM) to end preventable child deaths: a technical consultation and country action planning, 22-26 July 2019, Addis Ababa: web annex: summary tables with recommendations of high burden to high impact (HBHI) countries for scaling up integrated community case managementPublications · 28 juillet 2020
7192Protocole original pour la surveillance des délétions des gènes pfhrp2/3 et la mise en banque de matériel biologique en vue de recherches ultérieuresPublications · 28 juillet 2020
7193Institutionalizing integrated community case management (iCCM) to end preventable child deaths: a technical consultation and country action planning, 22-26 July 2019, Addis AbabaPublications · 28 juillet 2020
7194Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy: web annex E: framework for regional verification of the global control goal for hepatitis B surface antigen prevalence in children by 2020Publications · 27 juillet 2020
7195Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy: web annex C: impact and cost–effectiveness of HBV peripartum antiviral therapyPublications · 27 juillet 2020
7196Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy: web annex D: acceptability, feasibility, values and preferences of antiviral prophylaxis for HBV-infected pregnant women, in addition to timely birth dose vaccinationPublications · 27 juillet 2020
7197Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy: web annex A: systematic review of the efficacy and safety of antiviral therapy during pregnancyPublications · 27 juillet 2020
7198Compendium of good practices in the health sector response to viral hepatitis in the WHO European RegionPublications · 27 juillet 2020
7199Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy: web annex F: summary of declared interests of guideline development group membersPublications · 27 juillet 2020
7200Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy: web annex B: systematic review of the performance of hepatitis B e antigen test, as an alternative to HBV DNA, to assess eligibility for initiating antiviral therapy during pregnancyPublications · 27 juillet 2020